Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 606-630-8 | CAS number: 20765-98-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 12 February - 15 March 2007
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study, to GLP
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 007
- Report date:
- 2007
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Rhodium (III) chloride hydrate
- IUPAC Name:
- Rhodium (III) chloride hydrate
- Reference substance name:
- 20765-98-4, 13569-65-8
- IUPAC Name:
- 20765-98-4, 13569-65-8
- Test material form:
- other: liquid
- Details on test material:
- - Name of test material (as cited in study report): Rhodium (III) chloride hydrate, solution
- Substance type: No data
- Physical state: Red liquid
- Analytical purity: No data
- Impurities (identity and concentrations): No data
- Composition of test material, percentage of components: 15.95% RhCl3 without water, 1.78% HCl
- Isomers composition: Not applicable
- Purity test date: No data
- Lot/batch No.: 103/05
- Expiration date of the lot/batch: 30 April 2007
- Stability under test conditions: No data
- Storage condition of test material: Room temperature
Constituent 1
Constituent 2
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Winklemann
- Age at study initiation: 6-12 weeks at start of acclimatisation (minimum 7 weeks at start of treatment)
- Weight at study initiation: Males, 27-32; females, 23-28 g
- Assigned to test groups randomly: Yes
- Fasting period before study: No data
- Housing: 5 animals of the same sex per cage. Macrolon Type III (Hereto) cage with lignocel bedding.
- Diet (e.g. ad libitum): Altromin 1324 maintenance diet
- Water (e.g. ad libitum): Tap water ad libitum
- Acclimation period: One week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-25
- Humidity (%): 55 ± 10
- Air changes (per hr): No data
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: No data
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- - Vehicle(s)/solvent(s) used: Sodium chloride
- Justification for choice of solvent/vehicle: Solvent was chosen “according to its relative non-toxicity for the animals”. - Details on exposure:
- The test item was prepared and diluted in 0.9% NaCl within 1 hour before treatment. All anmals received a single volume intraperitoneal injection of 10 mL/kg bw
- Duration of treatment / exposure:
- Acute exposure
- Frequency of treatment:
- Single dose
- Post exposure period:
- 44 and (for the highest dose only) 68 hours
Doses / concentrations
- Remarks:
- Doses / Concentrations:
200, 500 and 1000 mg/kg bw
Basis:
nominal conc.
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Cyclophosphamide
- Justification for choice of positive control(s): No data
- Route of administration: Intraperitoneal
- Doses / concentrations: 40 mg/kg bw (10 mL/kg bw)
The solution is prepared on the day of administration.
Examinations
- Tissues and cell types examined:
- Erythrocytes
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: Due to the results obtained in the range-finding study, 1000 mg/kg bw was chosen as the maximum tolerable dose (MTD). The MTD is defined as the dose producing signs of toxicity such as lethargy, palpebral closure, prone position etc. Higher doses are anticipated to produce lethality within 48 hr.
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields): Single intraperitoneal treatment; exposition times were 44 hr for all dose groups and 68 hr for the negative control and the highest dose group.
DETAILS OF SLIDE PREPARATION: Blood cells obtained from the tail vein were immediately fixed in “ultracold” methanol, washed in Hank’s balanced salt solution, and centrifuged at 600 x g for 5 minutes (supernatant was subsequently discarded).
METHOD OF ANALYSIS: Evaluation of all samples performed using a flow cytometer at least 16 hr after fixation. At least 10,000 immature erythrocytes were evaluated for the presence of micronuclei from each animal. The total numbers of polychromatic (immature) erythrocytes among total erythrocytes (relative PCE [rel. PCE]) was calulated in order to detect a cytotoxic effect. - Evaluation criteria:
- A positive result is considered as either a dose-related increase in the number of micronucleated cells and/or a biologically relevant increase in the number of micronucleated cells for at least one of the dose groups.
A test item is considered to be negative if there is no biologically relevant and/or statistically significant increase in the number of micronucleated cells at any dose level. - Statistics:
- Nonparametric Mann-Whitney Test (p<0.05)
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- positive
- Toxicity:
- yes
- Remarks:
- Observed at the highest two doses: effects at 1000 mg/kg bw included reduction of spontaneous activity, apathy, palpebral closure, rough fur and cramps. Slight toxicity was apparent at 500 mg/kg bw
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- Dose range: 400 (one female), 1000 (3 mice/sex) and 2000 (one female) mg/kg bw
- Solubility: No data
- Clinical signs of toxicity in test animals: No toxic symptoms were seen in one female mouse following a single intraperitoneal injection of 400 mg/kg bw. In mice (3/sex) receiving an injection of 1000 mg/kg bw, systemic toxicity was seen (including reduction of spontaneous activity, prone position, cramps, apathy, palpebral closure and/or rough fur), but all survived 72 hours after treatment. One female received 2000 mg/kg bw, and died six hours after exposure.
- Evidence of cytotoxicity in tissue analyzed: No data
- Rationale for exposure: No data
- Harvest times: 30 minutes, 5 hours, 1 day and 2 days
- High dose with and without activation: 2000 mg/kg bw
RESULTS OF DEFINITIVE STUDY
- Types of structural aberrations for significant dose levels (for Cytogenetic or SCE assay): Not applicable
- Induction of micronuclei (for Micronucleus assay): All mean values of micronuclei formation following treatment with the test item were above the corresponding negative controls. A biologically relevant increase in the induction of micronucle was apparent. Further, this exhibited a dose-response relationship (see Table 1 for details).
- Ratio of PCE/NCE (for Micronucleus assay): The relative PCE was determined for each animal for the assessment of cytotoxicity. The negative control values noted at 44 hr were 2.13 for males and 1.57 for females while the analogous values at 68 hr were 2.67 and 2.62 respectively. These values were slightly above the range of the control data (1.38-2.08) as reported in the literature, aside from the 44-hr females. Relative PCE values for the treated groups were as follows (data for males and females respectively): 2.01 and 1.52 (0.2 MTD, 44 hr); 2.21 and 1.45 (0.5 MTD, 44 hr); 2.54 and 1.67 (1 MTD, 44 hr); 2.00 and 1.47 (1 MTD, 68 hr). These values were all within the range of the corresponding negative control.
- Appropriateness of dose levels and route: The dose levels were selected on the basis of the preliminary study
- Statistical evaluation: A statistically significant (p<0.05) increase in the frequency of blood cells with micronuclei was noted in the three test groups and the positive control group, when compared to the negative controls (see Table 2 for details).
Any other information on results incl. tables
Table 1: Percentage of blood cells with micronuclei
Dose group | Concentration (mg/kg bw) | Preparation time (h) | Male (%) | Female (%) |
Vehicle control | 0 | 44 | 0.31 | 0.20 |
Positive control | 40 | 44 | 2.25 | 1.72 |
1 MTD | 1000 | 44 | 2.57 | 2.48 |
0.5 MTD | 500 | 44 | 1.65 | 1.52 |
0.2 MTD | 200 | 44 | 0.90 | 0.97 |
Vehicle control | 0 | 68 | 0.32 | 0.21 |
1 MTD | 1000 | 68 | 0.73 | 0.56 |
MTD: Maximum tolerable dose
Table 2: Statistical significance at the 5% level (p<0.05)
Vehicle control versus test group | Preparation time (hr) | Significance | p-value | ||
Male | Female | Male | Female | ||
Positive control | 44 | + | + | 0.0079 | 0.0079 |
1 MTD | 44 | + | + | 0.0159 | 0.0079 |
0.5 MTD | 44 | + | + | 0.0079 | 0.0079 |
0.2 MTD | 44 | + | + | 0.0317 | 0.0079 |
1 MTD | 68 | + | + | 0.0159 | 0.0079 |
+: Significant
-: Not significant
The negative controls (24 and 48 hr) evaluated were within the range of the control data (0.15 -0.65%) reported in the literature.
The positive control (cyclophosphamide) induced a statistically significant increase in the induced micronucleus frequency (percentage of cells with micronuclei was 2.25 and 1.72% for males and females, respectively), thus demonstrating the validity of the assay.
The weight variation of treated animals (+/- 8.7 and 9.7% for males and females, respectively) did not exceed +/- 20% of the mean weight of each sex, thus fulfilling the data acceptance criteria.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): positive
In an in vivo guideline study, to GLP, rhodium (III) chloride hydrate solution induced a dose-related and statistically significant increase in the frequency of micronuclei in polychromatic erythrocytes of mice (5/sex/dose) following a single intraperitoneal injection at 200, 500, and 1000 mg/kg bw, when compared to the vehicle controls. - Executive summary:
An in vivo mammalian erythrocyte micronucleus test (conducted according to OECD test guideline 474, and to GLP) was performed to assess the potential of rhodium (III) chloride hydrate, solution to induce micronuclei in the blood cells of mice.
Following a range-finding study, groups of young healthy mice (5/sex/dose) were administered the test material in sodium chloride solution at 0, 200, 500, and 1000 (the MTD) mg/kg bw by single intraperitoneal injection. Peripheral blood was obtained from the tail vein 44 hours and (at the highest dose only) 68 hours after treatment. At least 10,000 polychromatic (immature) erythrocytes (PCEs) were counted from each animal, and scored for the presence of micronuclei. Additionally, the proportion of PCEs among total erythrocytes was calculated for each animal (rel. PCE).
A biologically relevant and dose-related increase in the incidence of micronucleated polychromatic erythrocytes was observed in all treated groups compared to the concurrent vehicle controls. The rel. PCE values were in the range of the corresponding vehicle control. Clinical signs of toxicity were observed at the two highest doses. Cyclophosphamide (positive control), administered intraperitoneally at 40 mg/kg bw, induced a significant increase in micronucleus frequency, demonstrating the adequacy of the assay.
In conclusion, rhodium (III) chloride hydrate solution induced a dose-related and statistically significant increase in the frequency of micronuclei in erythrocytes of mice following a single intraperitoneal injection at 200, 500, and 1000 mg/kg bw, when compared to the vehicle controls.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.